Navigation Links
Rigel to Present at BIO CEO & Investor Conference
Date:2/7/2013

SOUTH SAN FRANCISCO, Calif., Feb. 7, 2013 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower , the company's chairman and chief executive officer, is scheduled to present a company overview at the 15th Annual BIO CEO & Investor Conference in New York City on Monday, February 11th at 10:00 a.m. ET.

To access the live webcast of the presentation or the subsequent archived recording, log on to www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (www.rigel.com)

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral SYK inhibitor that is in Phase 3 clinical trials for rheumatoid arthritis with its partner AstraZeneca; R343, an inhaled SYK inhibitor for asthma and R333, a topical JAK/SYK inhibitor for discoid lupus – both of which have commenced Phase 2 clinical trials; and, R348, a topical JAK/SYK inhibitor in a Phase 1 clinical trial for the treatment of chronic dry eye.

Contact: Ryan Maynard 
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Rigel Announces First Quarter 2012 Financial Results
2. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
3. Rigel Announces Second Quarter 2012 Financial Results
4. Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
5. Rigel to Present at UBS Global Life Sciences Conference
6. Rigel Announces Third Quarter 2012 Financial Results
7. Rigel to Present at Jefferies 2012 Global Healthcare Conference in London
8. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
9. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
10. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... FRAMINGHAM, Mass. and SYDNEY , ... HTWR - ASX: HIN), a leading innovator of less ... of advanced heart failure, today announced that CEO ... 2013 UBS Global Healthcare Conference at 11:00 a.m. EDT on ... 20-22, 2013 at the Sheraton New York Hotel. ...
(Date:5/16/2013)...  Amgen (NASDAQ: AMGN ) will participate in ... 2013, at the Sheraton New York Times Square in ... Eastern Daylight Time. Joseph P. Miletich , ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
(Date:5/16/2013)... OrthoView PSL will allow individual ... the widely-used OrthoView digital templating software via the Cloud ... get started. OrthoView, the leading independent provider ... is dedicated to enabling orthopaedic surgeons in hospitals and ... printed film is unavailable. Over 5,000 orthopaedic surgeons in ...
Breaking Medicine Technology:HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2
(Date:5/18/2013)... Dubai (PRWEB) May 19, 2013 Illuminations is ... therapist Trisha Caetano. Seminars will take place over the ... 6, Friday, June 7, and Saturday, June 8, 2013. , ... of symptoms, but focuses on the attitudes, patterns and coping ... the symptoms. Participants will learn to live a more integrated ...
(Date:5/18/2013)... FL (May 18, 2013) The use of ... a colonoscopy, according to new research presented today ... which begins days in advance of the procedure, ... medication to be taken at strict intervals. The ... doctors to see cancer and precancerous polyps in ...
(Date:5/18/2013)... 2013) A ground-breaking advance in colonoscopy technology ... research presented today at Digestive Disease Week (DDW). ... time for colonoscopies and exploring safer methods for ... use a device called a colonoscope to examine ... allows a doctor to look for precancerous polyps ...
(Date:5/18/2013)... The “World Healthcare IT Market: Trends & Forecast ... drivers, restraints, and opportunities in North America, Europe, Asia, ... 89 market data tables , ... Market" , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html , Early ... global healthcare IT market is expected to grow from ...
(Date:5/18/2013)... KY (PRWEB) May 18, 2013 During ... hearing loss should consider the legal protections they have, ... when problems arise with their child’s treatment or hearing ... , Since 1927, the American Speech-Language-Hearing Association has used ... disorders and to promote treatment, such as cochlear implants, ...
Breaking Medicine News(10 mins):Health News:Illuminations Brings World Renowned Therapist to the Middle East 2Health News:New smartphone application improves colonoscopy preparation 2Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3
... pathways involved in cancer metastasis , , MONDAY, March 3 ... development of human embryonic stem cells can inhibit the ... cancers, says a study by researchers at Northwestern University ... online issue of the Proceedings of the National ...
... of,health care improved by an average 2.3 percent a ... important advances but points to an overall,slowing in quality ... for Healthcare Research and Quality., The improvement rate, ... Healthcare Disparities Report, is lower than,the 3.1 percent average ...
... that governs development of human embryonic stem cells (hESCs) ... the deadliest skin cancer, Northwestern University researchers have discovered. ... pigment cells or melanocytes, has a death rate of ... less than 7.5 months. , The Northwestern scientists, ...
... Mich. Researchers have long searched for a novel ... tumor cells. But finding a drug that kills the ... researchers. , Now, researchers at the University of ... that is highly effective in cell cultures at inhibiting ...
... 3 Shopko has some groundbreaking,news for Council Bluffs. The ... well as a fifth store to the suburban Omaha market. ... This month, Shopko will open the first new store to ... departure from the look and layout of,current Shopko stores. The ...
... Adds Another 450 Southern California Healthcare Employees, ... (USW) today said that over 450 service workers ... have voted in a secret ballot,election overseen by ... the,union, uniting them with about 160 technical workers ...
Cached Medicine News:Health News:Embryonic Stem Cell Protein Inhibits Melanoma 2Health News:Modest Health Care Quality Gains Outpaced by Spending 2Health News:Modest Health Care Quality Gains Outpaced by Spending 3Health News:Protein in embryonic stem cells control malignant tumor cells 2Health News:Protein in embryonic stem cells control malignant tumor cells 3Health News:U-M researchers ID promising new cancer drug 2Health News:Shopko Announces New Prototype Store in Council Bluffs 2Health News:Apple Valley SMMC Workers Choose USW 2
... into testing wells and read results. ... multiple drug screen cassette that can ... adulterants. It can test from one ... can be accompanied with four (4) ...
... Glucose Monitoring System is a patient insertable short-term ... the DexCom STS Receiver., The DexCom STS Sensor ... the DexCom STS Applicator by the user or ... held in place by an adhesive to the ...
... performing routine Holter,monitoring, the Burdick ... provides a,practical, no-nonsense diagnostic tool ... care,environment. This highly accurate and,easy-to-use ... variety,of configurations at a price ...
... PC-based ECG diagnostics complements transition to ... the incorporation of computer-based technology into ... diagnostic instrumentation have developed. Burdick's Universal ... EMRs making it the ideal choice ...
Medicine Products: